James M. Frates, CFO: Amylyx Pharmaceuticals AMLX Sell · Filed 02/04

Trade details

Type: Insider sale
Amount: $52,110.05
Shares · price: 3,557 sh · $14.65 a share
Held after: 173,547 sh
Stock: Amylyx Pharmaceuticals AMLX
Person: James M. FratesCFO
Trade date: 26/02/02
Filed: 26/02/04
Days to filing: 2 days

Sold 2.0% of holdings

Share of holding sold: 2.0%

Amylyx Pharmaceuticals trades, last 26 weeks

What else happened in Amylyx Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 01/03~03/04

James M. Frates's recent trades

James M. FratesCFO
Planned saleAmylyx Pharmaceuticals
Planned sale
Amylyx Pharmaceuticals
AMLX
$349.8K
10,810 sh
$349.8K
Filed 09/11
Traded 09/10
James M. FratesCFO
SellAmylyx Pharmaceuticals
Sell
Amylyx Pharmaceuticals
AMLX
$114.8K
7,909 sh
$114.8K
Filed 03/04
Traded 03/02
James M. FratesCFO
Planned saleAmylyx Pharmaceuticals
Planned sale
Amylyx Pharmaceuticals
AMLX
$114.9K
7,909 sh
$114.9K
Filed 03/02
Traded 03/02
James M. FratesCFO
Planned saleAmylyx Pharmaceuticals
Planned sale
Amylyx Pharmaceuticals
AMLX
$52.1K
3,557 sh
$52.1K
Filed 02/02
Traded 02/02
James M. FratesCFO
SellAmylyx Pharmaceuticals
Sell
Amylyx Pharmaceuticals
AMLX
$37K
3,326 sh
$37K
Filed 01/08
Traded 01/06